Neonatal Patent Ductus Arteriosus

Neonatal patent ductus arteriosus is a condition in which the ductus arteriosus, a normal fetal blood vessel between the pulmonary artery and aorta, remains open after birth. This vessel usually closes shortly after birth as the baby’s circulation changes and oxygen levels rise. If it stays open, blood can flow in an unusual direction and increase blood flow to the lungs. Patent ductus arteriosus is especially common in premature infants and may be mild or significant enough to affect breathing, feeding, or heart function.

Before birth, fetal circulation and chemical signals keep the ductus arteriosus open so blood can bypass the lungs. After birth, the baby’s first breaths raise oxygen levels, and the vessel usually constricts and closes. When it does not close, blood can move from the aorta toward the pulmonary artery, increasing blood flow to the lungs. This persistent ductus arteriosus can therefore change the normal circulation after birth.

The likelihood and clinical impact of patent ductus arteriosus generally increase as gestational age and birth weight decrease. Most of these risk factors are not modifiable by parents. A full-term infant with a small PDA may have few or no immediate effects.

Not every PDA causes complications. Risk depends on the size of the opening, the infant’s gestational age and overall health, and how much extra blood flow reaches the lungs. A hemodynamically significant PDA may place strain on the heart and lungs and may affect blood flow to other organs, particularly in premature infants.

Clinicians may suspect PDA after hearing a heart murmur or finding abnormal pulses, breathing or oxygenation concerns, feeding difficulty, or signs of excess blood flow. Some premature infants are identified through routine monitoring even before clear symptoms appear.

Echocardiography

Echocardiography is the key test used to confirm patent ductus arteriosus. This painless heart ultrasound can show the ductus, the direction and amount of blood flow, heart function, and effects on the lungs and heart. A chest X-ray, electrocardiogram, pulse oximetry, blood pressure checks, and laboratory tests may also assess the infant’s condition or help rule out other causes; they do not diagnose every PDA by themselves.

Some small or clinically quiet PDAs are monitored, while a PDA causing breathing, heart, or circulation problems may need medication or closure. The neonatal team bases the approach on gestational age, overall condition, echocardiogram findings, and response to treatment.

Monitoring and supportive care

Observation may be appropriate when a PDA is small or is not causing important symptoms or circulation problems. Clinicians may monitor breathing, oxygen needs, blood pressure, feeding, weight, urine output, and heart ultrasound findings. Follow-up may include repeat examinations or echocardiograms to see whether the PDA closes and whether heart and lung function remain stable.

Medication to encourage closure

When treatment is needed, medicines such as ibuprofen, indomethacin, or acetaminophen may encourage the PDA to close, especially in some premature infants. The team chooses a medicine based on the infant’s age, kidney function, bleeding risk, intestinal health, and other medical factors, and monitors blood tests and organ function as appropriate. These medicines may not be suitable for every newborn, and a PDA that remains open may be monitored or considered for closure.

Catheter or surgical closure

Selected infants may have catheter-based device closure or surgical ligation when medication is unsuitable or unsuccessful and the PDA continues to affect circulation. Catheter closure uses a device delivered through a blood vessel, while surgical ligation closes the vessel through an operation. Catheter closure may not be suitable for the smallest or youngest infants; procedural risks can include bleeding, infection, blood-vessel injury, or effects on nearby structures. Recovery depends on the infant’s overall health, and the care team monitors breathing, circulation, feeding, and follow-up echocardiograms afterward.

Many small PDAs close on their own or after treatment, and outcomes are often good when a significant PDA is recognized and managed. Extremely premature or medically fragile infants may face greater risks related to lung disease, heart strain, or other complications. The outlook depends on gestational age, PDA size, associated health problems, and response to treatment.

Follow-up with neonatal or pediatric cardiology may include repeat examinations or echocardiograms. These checks confirm closure when appropriate, assess heart and lung function, and monitor growth and development.

Do not wait for a routine appointment when a newborn has new or worsening breathing, feeding, color, or alertness changes. Follow the care plan provided by the NICU or pediatric cardiology team, including instructions about when and where to seek urgent care.